Biopsy Devices: Technologies and Global Markets

May 2023| HLC171C| BCC Publishing

Report Highlights

The global biopsy devices market should reach $3.1 billion by 2027 from $2.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.8% for the forecast period of 2022 to 2027.

Report Includes

  • 44 data tables and 21 additional tables
  • Detailed overview and an up-to-date analysis of the global market for biopsy devices
  • Analyses of the global market trends, with revenue data (sales figures) for 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for the global biopsy devices market, and corresponding market share analysis by device type, therapeutic area/application, image guiding technology, end user, and region
  • Identification of the viable technology drivers and barriers through a holistic review of various next generation imaging technologies used in the process of performing biopsies and their key therapeutic areas in the cancer diagnostics market
  • Review of cancer statistics and epidemiology insights and SWOT analysis of various cancer biotherapeutics present in the market
  • A look at major issues and trends with relate to the R&D of more effective cancer treatment, and new cancer therapeutics in development, and outlook on cancer clinical trials
  • Assessment of the market growth opportunities, SWOT analysis of the leading companies engaged in manufacturing and development of biopsy devices, emerging trends and technology developments, along with the COVID-19 implications on the marketplace
  • Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
  • Patent grants and patent applications on biopsy devices and cancer diagnostics industry
  • Descriptive company profiles of the leading market players, including Argon Medical Devices Inc., Boston Scientific Corp., FujiFilm Holdings Corp., Mammotome, and Olympus Corp.

Report Scope

This research report presents an in-depth analysis of the global market for biopsy devices, segmented by product type, imaging technique, application, end user and geographic markets. It discusses key devices (vacuum-assisted biopsy [VAB] devices, fine needle aspiration biopsy [FNAB] devices, core needle biopsy [CNB] devices, biopsy guidance systems, biopsy needles, biopsy forceps and others). Applications include trends and market estimates of key application areas (breast cancer, gastrointestinal cancer, lung cancer, liver cancer, prostate cancer and cervical cancer, among others). This report focuses on key imaging technologies used in the process of performing biopsies (ultrasound, magnetic resonance imaging [MRI], computed tomography [CT] and others). The report also reviews the supply chain from manufacturers to surgeons.

The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.

Frequently Asked Questions (FAQs)

The Biopsy Devices market is projected to grow from $2.1 billion in 2021 to $3.1 billion in 2027, at a compound annual growth rate (CAGR) of 6.8% during the forecast period.
The key factors driving the growth of the biopsy devices market include the growing prevalence of cancer globally, increasing demand for minimally invasive biopsy techniques, initiatives undertaken by government & global health organizations to spread awareness about cancer, rapid technological advancements, and the improved reimbursement scenario in the U.S. are the attributable factors propelling the growth of this market.
The biopsy device market is segmented based on product type, application, imaging-guiding technology, and end-user.
Biopsy Guiding Systems segment will dominate the market by the end of 2027.
North America holds the highest share of the market.
Key companies in the market include Becton, Dickinson and Company (BD), Hologic, Boston Scientific Corp., Merit Medical Systems, Medtronic, B. Braun Melsungen AG, Cardinal Health., Danaher Corp. (Mammotome), Argon Medical, Olympus America, Cook Medical, Conmed, FUJIFILM, mdxhealth, and INRAD.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $2.1 billion
Market size forecast $3.1 billion
Growth rate CAGR of 6.8%
Units considered $ Millions
Segments covered product type, application, imaging-guiding technology, and end-user
Regions covered North America, Europe, Asia-Pacific, and ROW
Countries covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
Key Market Drivers
  • Growing Prevalence of Chronic Diseases
  • Increasing Preference for Minimally Invasive Procedures
  • Increased Public Awareness of Disease Screening
  • Increasing Aging Population
  • Improved Reimbursement Policies in Developing Economies
  • Technological Advancements in Imaging Technology
Companies studied
  • ARGON MEDICAL DEVICES
  • B. BRAUN MELSUNGEN AG
  • BD
  • BOSTON SCIENTIFIC CORP.
  • CARDINAL HEALTH
  • CONMED CORP.
  • COOK
  • DTR MEDICAL LTD.
  • MAMMOTOME DEVICOR MEDICAL PRODUCTS INC.
  • FUJIFILM HOLDINGS CORP.
  • HOLOGIC INC.
  • INRAD INC.
  • MERIT MEDICAL SYSTEMS
  • MDNA LIFE SCIENCES INC.
  • MAUNA KEA TECHNOLOGIES
  • MEDTRONIC
  • MDXHEALTH INC.
  • OLYMPUS CORP.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Biopsy Devices: Technologies and Global Markets136Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Overview of Biopsy Devices15Free
Chapter- 4: Biopsy Device Market by Product Type20Free
Chapter- 5: Biopsy Device Market by Imaging Guiding Technology11Free
Chapter- 6: Biopsy Device Market by Application15Free
Chapter- 7: Biopsy Device Market by End User4Free
Chapter- 8: Biopsy Device Market by Region10Free
Chapter- 9: COVID-19 Impact 1Free
Chapter- 10: Emerging Technologies in the Biopsy Device Market1Free
Chapter- 11: Patent Review6Free
Chapter- 12: Competitive Landscape3Free
Chapter- 13: Company Profiles35Free
Chapter- 14: Appendix A: Company Addresses and Contact Details2Free
Chapter- 15: Appendix B: Abbreviations1Free
Published - Mar-2016| Analyst - Yojana Jeevane| Code - HLC171B

Report Highlights

The global market for biopsy devices should reach around roughly $2.1 billion by 2020 from over $1.5 billion in 2015, a compound annual growth rate (CAGR) of 6.2% from 2015 to 2020.

Report Includes

  • An overview of the global biopsy devices market.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Segmented analyses based on devices, therapeutic segments, and geographies
  • Information on key devices such as breast biopsy devices, CNB (core needle biopsy) devices, fine needles, gastro intestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and non–thermal ablation techniques
  • Analyses of key strategies, competitive insights, and developments of key companies in the market
  • Information on both the challenges that must be addressed and opportunities that can be leveraged by market participants
  • Evaluation of key and relevant patents
  • Analysis of the key strategies, competitive insights and development of key companies in the market
Published - Jun-2014| Analyst - Yojana Jeevane| Code - HLC171A

Report Highlights

The global market for biopsy devices reached $1.4 billion in 2013. This market is further expected to grow to $1.5 billion in 2014 and $1.9 billion in 2018, a compound annual growth rate (CAGR) of 6.3% over the five year period, 2013 to 2018.

Report Includes

  • An overview of the global biopsy devices market. 
  • Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Segmented analyses based on devices, therapeutic segments, and geographies.
  • Analyses of key strategies, competitive insights, and developments of key companies in the market.
  • Information on both the challenges that must be addressed and opportunities that can be leveraged by market participants.
  • Evaluation of key and relevant patents.
  • Comprehensive profiles of leading companies in the industry.

Biopsy Devices: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS